Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2023

Mar 3, 2023

33625_dirs_2023-03-02_7f25cfbd-e9f3-4cde-bd43-fdbcf5f99dc0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2023-02-28

Reporting Person: Shabshab Nabil (Director, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-01 Common Stock A 7810 $0.00 Acquired 29036 Direct
2023-03-01 Common Stock F 3873 $15.56 Disposed 25163 Direct
2023-03-01 Common Stock M 16702 $0.00 Acquired 41865 Direct
2023-03-01 Common Stock F 8362 $15.56 Disposed 33503 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Restricted Stock Unit $ M 1568 Disposed Common Stock (1568) Direct
2023-03-01 Restricted Stock Unit $ M 2117 Disposed Common Stock (2117) Direct
2023-03-01 Restricted Stock Unit $ M 13017 Disposed Common Stock (13017) Direct
2023-02-28 Restricted Stock Unit $ A 70197 Acquired Common Stock (70197) Direct

Footnotes

F1: The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022.

F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted stock award granted on March 1, 2022 and vested on March 1, 2023.

F3: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023.

F4: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F5: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the
remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.

F6: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the
restricted stock units will vest in 1/8th quarterly installments over the following 2 years.

F7: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

F8: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.